These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19096817)

  • 1. [Glucocorticoids and hypertension].
    Dodt C; Wellhöner JP; Schütt M; Sayk F
    Internist (Berl); 2009 Jan; 50(1):36-41. PubMed ID: 19096817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of arterial hypertension in the Itsenko-Cushing syndrome].
    Trofimoav IV; Golikov PP; Bogatyrev OP; Poliakova GA; Nikolaeva NIu
    Klin Med (Mosk); 2001; 79(8):18-20. PubMed ID: 11588777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome in Cushing's Syndrome Patients.
    Ferraù F; Korbonits M
    Front Horm Res; 2018; 49():85-103. PubMed ID: 29894989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercortisolism in obesity-associated hypertension.
    Varughese AG; Nimkevych O; Uwaifo GI
    Curr Hypertens Rep; 2014 Jul; 16(7):443. PubMed ID: 24801134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-dependent hypertension.
    Mantero F; Boscaro M
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):409-13. PubMed ID: 1390289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism.
    Seki Y; Morimoto S; Saito F; Takano N; Kimura S; Yamashita K; Yoshida N; Bokuda K; Sasaki N; Yatabe M; Watanabe D; Yatabe J; Ando T; Amano K; Kawamata T; Ichihara A
    J Clin Endocrinol Metab; 2019 May; 104(5):1788-1791. PubMed ID: 30561712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease.
    Ferrari P
    Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):575-89. PubMed ID: 14687590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing, cortisol, and cardiovascular disease.
    Whitworth JA; Mangos GJ; Kelly JJ
    Hypertension; 2000 Nov; 36(5):912-6. PubMed ID: 11082166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
    Frey FJ; Odermatt A; Frey BM
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease.
    Walker BR
    Endocr Res; 1996 Nov; 22(4):701-8. PubMed ID: 8969930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration.
    Starkman MN
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):477-88. PubMed ID: 24011881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is pseudo-Cushing's syndrome in a critically ill patient "pseudo"? Hypothesis and supportive case report.
    Kem DC; Metcalf JP; Cornea A; Dunnam M; Engelbrecht A; Yu X
    Endocr Pract; 2007; 13(2):153-8. PubMed ID: 17490929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome, glucocorticoids and the kidney.
    Smets P; Meyer E; Maddens B; Daminet S
    Gen Comp Endocrinol; 2010 Oct; 169(1):1-10. PubMed ID: 20655918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
    Stewart PM
    Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced hypertension: from mouse to man.
    Whitworth JA; Schyvens CG; Zhang Y; Mangos GJ; Kelly JJ
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):993-6. PubMed ID: 11903301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches and new advances in endocrine hypertension.
    Pacak K; Koch CA; Eisenhofer G
    Trends Endocrinol Metab; 2002 Apr; 13(3):96-7. PubMed ID: 11893518
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoid excess and hypertension.
    Baid S; Nieman LK
    Curr Hypertens Rep; 2004 Dec; 6(6):493-9. PubMed ID: 15527696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid Sexual Dimorphism in Metabolism: Dissecting the Role of Sex Hormones.
    Kroon J; Pereira AM; Meijer OC
    Trends Endocrinol Metab; 2020 May; 31(5):357-367. PubMed ID: 32037025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome.
    Huizenga NA; De Herder WW; Koper JW; de Lange P; v D Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    Eur J Endocrinol; 2000 May; 142(5):472-6. PubMed ID: 10802524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.